[1]
|
Zanconato, F., Cordenonsi, M. and Piccolo, S. (2016) YAP/TAZ at the Roots of Cancer. Cancer Cell, 29, 783-803.
https://doi.org/10.1016/j.ccell.2016.05.005
|
[2]
|
Huang, J., Wu, S., Barrera, J., Matthews, K. and Pan, D. (2005) The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Dro-sophila Homolog of YAP. Cell, 122, 421-434.
https://doi.org/10.1016/j.cell.2005.06.007
|
[3]
|
Warren, J.S.A., Xiao, Y. and Lamar, J.M. (2018) YAP /TAZ Acti-vation as a Target for Teating Metastatic Cancer. Cancers (Basel), 10, pii: E115. https://doi.org/10.3390/cancers10040115
|
[4]
|
李桂兰, 张丽, 闫华超. Hippo信号通路与肿瘤发生相关性研究进展[J]. 基础医学与临床, 2010, 30(9): 1002-1004.
|
[5]
|
Ma, Y., Yang, Y., Wang, F., et al. (2015) Hippo-YAP Sig-naling Pathway: A New Paradigm for Cancer Therapy. International Journal of Cancer, 137, 2275-2286. https://doi.org/10.1002/ijc.29073
|
[6]
|
Kemppainen, K., Wentus, N., Lassila, T., et al. (2016) Sphingosylphosphor-yl-choline Regulates the Hippo Signaling Pathway in a Dual Manner. Cell Signal, 28, 1894-1903. https://doi.org/10.1016/j.cellsig.2016.09.004
|
[7]
|
Pei, T.M. and Li, Y.J. (2015) YAP Is a Critical Oncogene in Human Cholangiocarcinoma. Oncotarget, 6, 17206-17220.
https://doi.org/10.18632/oncotarget.4043
|
[8]
|
Chaikuad, A. and Bullock, A.N. (2016) Structural Basis of Intracel-lular TGF-Beta Signaling: Receptors and Smads. Cold Spring Harbor Perspectives in Biology, 8, a022111. https://doi.org/10.1101/cshperspect.a022111
|
[9]
|
Kim, M.H. and Kim, J. (2017) Role of YAP/TAZ Transcriptional Regulators in Resistance to Anti-Cancer Therapies. Cellular and Molecular Life Sciences, 74, 1457-1474. https://doi.org/10.1007/s00018-016-2412-x
|
[10]
|
Kang, W., Tong, J.H., Chan, A.W., Lee, T.L., Lung, R.W., Leung, P.P., et al. (2011) Yes-Associated Protein 1 Exhibits Oncogenic Property in Gastric Cancer and Its Nuclear Accumula-tion Associates with Poor Prognosis. Clinical Cancer Research, 17, 2130-2139. https://doi.org/10.1158/1078-0432.CCR-10-2467
|
[11]
|
Hu, X., Xin, Y., Xiao, Y. and Zhao, J. (2014) Overexpres-sion of YAP1 Is Correlated with Progression, Metastasis and Poor Prognosis in Patients with Gastric Carcinoma. Pa-thology and Oncology Research, 20, 805-811.
https://doi.org/10.1007/s12253-014-9757-y
|
[12]
|
Lam-Himlin, D.M., Daniels, J.A., Gayyed, M.F., et al. (2016) The Hippo Pathway in Human Upper Gastrointestinal Dysplasia and Carcinoma: A Novel Oncogenic Pathway. Interna-tional Journal of Gastrointestinal Cancer, 37, 103-109.
|
[13]
|
Liu, H.B., Mei, D., Xu, P.C., Wang, H.S. and Wang, Y. (2019) YAP Promotes Gastric Cancer Cell Survival and Migration/Invasion via the ERK/Endoplasmic Reticulum Stress Pathway. Oncology Letters, 18, 6752-6758.
https://doi.org/10.3892/ol.2019.11049
|
[14]
|
Yan, H.Z., Qiu, C.M., Sun, W.W., Gu, M.M., et al. (2018) Yap Regu-lates Gastric Cancer Survival and Migration via SIRT1/Mfn2/Mitophagy. Oncology Reports, 39, 1671-1681. https://doi.org/10.3892/or.2018.6252
|
[15]
|
Han, T., Cheng, Z.W., Xu, M.L., Wang, X.M., Wu, J. and Fang, X.S. (2020) Yes-Associated Protein Contributes to Cell Proliferation and Migration of Gastric Cancer via Activation of Gli1. OncoTargets and Therapy, 13, 10867-10876.
https://doi.org/10.2147/OTT.S266449
|
[16]
|
Sun, D., Li, X., He, Y., et al. (2016) YAP1 Enhances Cell Proliferation, Migration, and Invasion of Gastric Cancer in Vitro and in Vivo. Oncotarget, 7, 81062-81076. https://doi.org/10.18632/oncotarget.13188
|
[17]
|
Li, N.S., Lu, N.H. and Xie, C. (2019) The Hippo and Wnt Signal-ling Pathways: Crosstalk during Neoplastic Progression in Gastrointestinal Tissue. The FEBS Journal, 286, 3745-3756. https://doi.org/10.1111/febs.15017
|
[18]
|
Ling, H.-H., Kuo, C.-C., et al. (2017) Elevation of YAP Promotes the Ep-ithelial-Mesenchymal Transition and Tumor Aggressiveness in Colorectal Cancer. Experimental Cell Research, 350, 218-225.
https://doi.org/10.1016/j.yexcr.2016.11.024
|
[19]
|
Ling, H.-H., Kuo, C.-C., et al. (2017) Elevation of YAP Promotes the Epithelial-Mesenchymal Transition and Tumor Aggressiveness in Colorectal Cancer. Experimental Cell Research, 350, 218-225.
|
[20]
|
Cho, S.Y., Gwak, J.W., Shin, Y.C., Moon, D., Ahn, J., Sol, H.W., Kim, S., Kim, G., Shin, H.M., Lee, K.H., Kim, J.Y. and Kim, J.S. (2018) Expression of Hippo Pathway Genes and Their Clinical Significance in Colon Adenocarcinoma. Oncology Letters, 15, 4926-4936. https://doi.org/10.3892/ol.2018.7911
|
[21]
|
Verboven, E., Moya, I.M., et al. (2021) Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis. Gastroenterology, 160, 847-862. https://doi.org/10.1053/j.gastro.2020.10.035
|
[22]
|
Liu, Y., Lu, T.F., Zhang, C., Xu, J., Xue, Z.Z., et al. (2019) Activation of YAP Attenuates Hepatic Damage and Fibrosis in Liver Ische-mia-Reperfusion Injury. Journal of Hepatology, 71, 719-730.
https://doi.org/10.1016/j.jhep.2019.05.029
|
[23]
|
Miyamura, N. and Nishina, H. (2018) YAP Regulates Liver Size and Function. Cell Cycle, 17, 267-268.
https://doi.org/10.1080/15384101.2017.1407390
|
[24]
|
Muyesai, N., Abulajiang, S., Adelijiang, T., et al. (2016) Clinical and Experimental Analysis of Platelet Microparticles Inducing Thrombosis after Coronary Stenting. Clinical La-boratory, 62, 1619-1624.
https://doi.org/10.7754/Clin.Lab.2016.150534
|
[25]
|
Sun, X., He, S., Wara, A.K., et al. (2014) Systemic Delivery of microRNA-181b Inhibits Nuclear Factor-B Activation, Vascular Inflammation, and Atherosclerosis in Apolipoprotein E-Deficient Mice. Circulation Research, 114, 32-40.
https://doi.org/10.1161/CIRCRESAHA.113.302089
|
[26]
|
Pei, T.M., Li, Y.J., Wang, J.B., et al. (2015) YAP Is a Critical Oncogene in Human Cholangiocarcinoma. Oncotarget, 6, 17206-17220. https://doi.org/10.18632/oncotarget.4043
|
[27]
|
Loforese, G., Malinka, T., Keogh, A., et al. (2017) Impaired Liver Regeneration in Aged Mice Can Be Rescued by Silencing Hippo Core Kinases MST1 and MST2. EMBO Molecular Medicine, 9, 46-60.
https://doi.org/10.15252/emmm.201506089
|
[28]
|
Hong, L., Cai, Y., Jiang, M., et al. (2015) The Hippo Signaling Pathway in Liver Regeneration and Tumorigenesis. Acta Biochimica et Biophysica Sinica (Shanghai), 47, 46-52. https://doi.org/10.1093/abbs/gmu106
|
[29]
|
Ma, W.B., Han, C., Zhang, J.Q., Song, K., Chen, W.N., Kwon, H. and Wu, T. (2020) The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway. Hepatology, 72, 1283-1297. https://doi.org/10.1002/hep.31141
|
[30]
|
Jeffffery, N. and Harries, L.W. (2016) b-Cell Differentiation Status in Type 2 Diabetes. Diabetes, Obesity and Metabolism, 18, 1167-1175. https://doi.org/10.1111/dom.12778
|
[31]
|
Haataja, L., Gurlo, T., Huang, C.J. and Butler, P.C. (2008) Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis. Endocrine Reviews, 29, 303-316. https://doi.org/10.1210/er.2007-0037
|
[32]
|
Poitout, V. and Robertson, R.P. (2008) Glucolipotoxicity: Fuel Excess and Beta-Cell Dysfunction. Endocrine Reviews, 29, 351-366. https://doi.org/10.1210/er.2007-0023
|